CCT2012 Final Program(PDF)

Complex
Cardiovascular
Therapeutics
2O12
Live PCI Live Case Transmission LIVE J Main Theater
Sunday, November 4
Toyohashi Heart Center
Operators
Etsuo Tsuchikane, Yasumi Igarashi, Masahiko Ochiai
Cath Lab Advisor
Sudhir Rathore
IVUS Commentator
Masashi Kimura
8:30-10:30 PCI Live Case Transmission 9
CTO Course
Chairs
Kinzo Ueda, Masahisa Yamane, Gerald S. Werner
Commentators
Shinya Fujita, Shahid Merchant, Tsuyoshi Oda, Koji Oku,
Makoto Sekiguchi, Georgios Sianos, Takafumi Tsuji
10:30-12:00 PCI Live Case Transmission 10
CTO Course
10:30-12:00
Catch the new devices at the forefront of
CTO-PCI treatment
Co-sponsored by
ASAHI INTECC CO., LTD.
ASAHI INTECC J-sales, INC.
Chairs
Yasushi Asakura, Masahisa Yamane, Nicolaus J. Reifart
Commentators
Mitsunori Abe, Pravin K. Goel, Takashi Matsukage, Yuichi Noguchi,
Takeshi Serikawa, Darren Walters, Ryohei Yoshikawa
13:00-16:00 PCI Live Case Transmission 11·12
CTO Course "Antegrade Summit"
Chairs
Yasushi Asakura, Kinzo Ueda
Discussers
Osamu Katoh, Wataru Nagamatsu, Yuji Oikawa, Satoru Tohara
What should we learn from pathological findings
for antegrade approach? - microvascular
channels, loose tissue or something else?
Gaku Nakazawa
How should we improve the traditional antegrade
approach for the next step? - insight from
3D-IVUS
Kenya Nasu
What's our mistakes in developing antegrade
techniques? - simplified way or elaborate way?
Osamu Katoh
Chairs
Eisho Kyo, Yoshinori Yasaka
Discussers
Osamu Katoh, Sum Kin Leung, Kenya Nasu, Satoru Otsuji,
Gerald S. Werner, Ryohei Yoshikawa
IVUS findings indicating limitations of re-entry
mechanism
Scott Andrew Harding
Mechanisms and limitations of re-entry - Is there
any role for new re-entry devices or techniques in
evolving the antegrade approach to CTOs?
Eisho Kyo
Further evolution of antegrade approach - What
are requirements for the next step?
Masahisa Yamane
Co-sponsored by
TOSHIBA MEDICAL SYSTEMS CORPORATION
22